CAVALTINIB

Serial Number 88894180
606

Registration Progress

Application Filed
Apr 29, 2020
Under Examination
Feb 16, 2021
Approved for Publication
Dec 22, 2020
Published for Opposition
Dec 22, 2020
Registered

Trademark Image

CAVALTINIB

Basic Information

Serial Number
88894180
Filing Date
April 29, 2020
Published for Opposition
December 22, 2020
Abandonment Date
March 18, 2024
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 18, 2024
Classes
005

Rights Holder

Biologic Publishing, Inc.

03
Address
688 - 2397 King George Hwy
White Rock V4A7E9
CA

Ownership History

Biologic Publishing, Inc.

Original Applicant
03
White Rock CA

Biologic Publishing, Inc.

Owner at Publication
03
White Rock CA

Legal Representation

Attorney
James Surber

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

37 events
Date Code Type Description
Mar 18, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Mar 18, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 23, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 23, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 23, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 18, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 17, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 17, 2023 EX5G S SOU EXTENSION 5 GRANTED
Aug 9, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 9, 2023 EXT5 S SOU EXTENSION 5 FILED
Feb 17, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 15, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 15, 2023 EXT4 S SOU EXTENSION 4 FILED
Feb 15, 2023 EX4G S SOU EXTENSION 4 GRANTED
Oct 3, 2022 DOCK D ASSIGNED TO EXAMINER
Aug 16, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 12, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 12, 2022 EXT3 S SOU EXTENSION 3 FILED
Aug 12, 2022 EX3G S SOU EXTENSION 3 GRANTED
Feb 17, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 15, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 15, 2022 EXT2 S SOU EXTENSION 2 FILED
Feb 15, 2022 EX2G S SOU EXTENSION 2 GRANTED
Aug 7, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 5, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 5, 2021 EXT1 S SOU EXTENSION 1 FILED
Aug 5, 2021 EX1G S SOU EXTENSION 1 GRANTED
Feb 16, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 22, 2020 PUBO A PUBLISHED FOR OPPOSITION
Dec 22, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 2, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 20, 2020 DOCK D ASSIGNED TO EXAMINER
Aug 18, 2020 DOCK D ASSIGNED TO EXAMINER
Jul 22, 2020 DOCK D ASSIGNED TO EXAMINER
May 13, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 2, 2020 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Dietary supplements for inhibition of NF-Kappa-B and MSK1; Dietary supplements for prevention and treatment of respiratory distress, inflammation, inflammation associated with infections, autoinflammatory disorders, and autoimmune disorders; Pharmaceutical preparations for the treatment and prevention of respiratory distress, inflammation, inflammation associated with infections, autoinflammatory disorders, and autoimmune disorders
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...